# Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer

> **NCT00023673** · PHASE1,PHASE2 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 63 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** paclitaxel
- **RADIATION:** three-dimensional conformal radiation therapy

## Key facts

- **NCT ID:** NCT00023673
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-07
- **Primary completion:** 2009-01
- **Final completion:** 2013-11
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2017-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00023673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00023673, "Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00023673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*